cyclopia sequence: Clinical Trials

123 trials for cyclopia sequence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

67 completed, 23 unknown, 13 terminated, 9 recruiting. 51 Phase 2, 27 Phase 3, 26 Phase 1, 21 Phase 4, 11 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 251Completed 30, Terminated 8, Unknown 5, Recruiting 4, Withdrawn 4
Phase 327Unknown 10, Completed 8, Recruiting 6, Terminated 2, Not yet recruiting 1
Phase 126Completed 15, Terminated 3, Unknown 3, Withdrawn 3, Recruiting 1, Suspended 1
Phase 421Completed 11, Unknown 6, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Not applicable11Completed 7, Unknown 2, Not yet recruiting 1, Terminated 1
Early Phase 12Not yet recruiting 1, Recruiting 1

Follow cyclopia sequence: new trials by email Literature Review of cyclopia sequence trials Research Report on cyclopia sequence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Minocycline for CARP
Topical Minocycline Foam FXFM244, Control - Confluent and Reticulated Papillomatosis (CARP)
Early Phase 1Not yet recruitingMedical University of South Carolina352026-12-152026-10-22
Optimizing H. Pylori Eradication Regimen Under Intensified Acid Suppression
Keverprazan Hydrochloride 20 mg TID, Minocycline 100 mg (10-Day Regimen), Keverprazan Hydrochloride 20 mg BID - HELICOBACTER PYLORI INFECTIONS
Phase 4Not yet recruitingQilu Hospital of Shandong University3162026-08-012026-08-06
Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis
Minocycline Hydrochloride Capsule (50 mg per capsule), Placebo of Minocycline Hydrochloride Capsule (50 mg per capsule, containing 0 mg of minocycline) - Ischaemic Stroke
Phase 3RecruitingBeijing Tiantan Hospital9342026-06-052026-07-01
Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)
Minocycline hydrochloride capsule, Placebo capsules of Minocycline hydrochloride capsules - Acute Ischemic Stroke, Vessel Occlusion
Phase 2 / Phase 3RecruitingXiang Luo8602026-05-212026-05-27
Minocycline After Successful Endovascular Thrombectomy Recanalization in Posterior Circulation Arterial Occlusion (ATTRACTION-MINOP)
Minocycline hydrochloride capsule, Placebo capsules of Minocycline hydrochloride capsules - Acute Ischemic Stroke, Endovascular Thrombectomy
Phase 2 / Phase 3RecruitingXiang Luo2342026-05-192026-05-22
Clinical Study of Minocycline Hydrochloride Injectable Hydrogel for the Treatment of Periodontitis
treatment group - Periodontitis
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College802026-05-012026-05-28
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Minocycline hydrochloride capsules, Placebo capsules of Minocycline hydrochloride capsules - Intracerebral Hemorrhage
Phase 3RecruitingBeijing Tiantan Hospital11922026-04-022026-04-23
Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics
local antibiotic application of topical minocycline, Scaling and Root Planing - Periodontitis, Diabetes Mellitus Type 2
Early Phase 1RecruitingCase Western Reserve University422026-02-062026-02-19
Minocycline in Stroke Study at Maimonides
Minocycline 200mg - Stroke, Ischemia Stroke
Phase 2 / Phase 3RecruitingJoyce Chen11642026-02-022026-03-19
Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
Minocyclin - Acute Ischemic Stroke
Phase 2WithdrawnState University of New York at Buffalo2025-12-012026-03-06
Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery
Amiodarone, Minocycline - Atrial Fibrillation
Phase 2WithdrawnBaystate Medical Center2025-09-032026-09-30
A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa
Minocycline 100mg, Minocycline 200mg, Placebo - Retinitis Pigmentosa, Inherited Retinal Dystrophy
Phase 3Not yet recruitingZhongshan Ophthalmic Center, Sun Yat-sen University1262025-07-152025-07-24
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
Minocycline Hydrochloride, Placebo - Hypertension, Resistant to Conventional Therapy
Phase 4RecruitingUniversity of Florida1202025-01-082026-10-13
PRF + Minocycline vs Arestin in Non-surgical Perio Therapy
Arestin, PRF + M - Non-surgical Periodontal Therapy
Phase 4CompletedCenter for Advanced Rejuvenation and Esthetics152024-12-012026-05-28
High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection
Vonoprazan, Amoxicillin, Bismuth Potassium Citrate - Helicobacter Pylori Infection
Phase 4UnknownShanghai Jiao Tong University School of Medicine2002024-08-212024-12-30
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
Vonoprazan, Bismuth Potassium Citrate, Tetracycline,Metronidazole - Helicobacter Pylori Infection
Phase 4CompletedShanghai Jiao Tong University School of Medicine4802024-08-212026-03-25
Efficacy of Noisome as A Carrier of Locally Delivered Minocycline Hydrochloride Gel
Minocycline hydrochloride with noisome carrier, Minocycline Hydrochloride only - Periodontitis
Phase 2 / Phase 3UnknownAin Shams University302024-02-252024-02-12
Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.
esomeprazole, Bismuth, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis
Phase 4UnknownXijing Hospital of Digestive Diseases5482023-11-202024-09-19
Maimonides Minocycline in Stroke Study
Minocycline - Stroke, Acute, Ischemic Stroke
Phase 2 / Phase 3TerminatedMaimonides Medical Center22023-11-012025-12-17
Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea
minocycline, tranilast - Rosacea
Phase 4UnknownSecond Affiliated Hospital of Xi'an Jiaotong University452023-10-162024-03-12

Showing 20 of 123. Sign in to see all of them.

Narrower conditions

Ischemic Stroke (11)  ·  Schizophrenia (7)  ·  Stroke (7)  ·  Depressive Disorder, Major (5)  ·  Inflammation (5)  ·  Cerebral Hemorrhage (4)  ·  Pneumothorax (4)  ·  Acne Vulgaris (3)  ·  Alcoholism (3)  ·  Bipolar Disorder (3)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Depression (3)  ·  Depressive Disorder, Treatment-Resistant (3)  ·  Hemorrhagic Stroke (3)

Broader conditions

Nervous System Diseases (43)  ·  Central Nervous System Diseases (29)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Mental Disorders (26)  ·  Brain Diseases (23)  ·  Cardiovascular Diseases (22)  ·  Vascular Diseases (21)  ·  Pathologic Processes (19)  ·  Cerebrovascular Disorders (17)  ·  Neoplasms (14)  ·  Neoplasms by Site (12)  ·  Immune System Diseases (10)  ·  Respiratory Tract Diseases (10)  ·  Signs and Symptoms (10)  ·  Skin and Connective Tissue Diseases (10)

Interventions

Minocycline (106)  ·  Sugars (10)  ·  Surveys and Questionnaires (8)  ·  Tetracycline (5)  ·  Amoxicillin (4)  ·  Modafinil (4)  ·  Celecoxib (3)  ·  Esomeprazole (3)  ·  Metronidazole (3)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (2)  ·  Bupropion (2)  ·  Clarithromycin (2)  ·  Creatine (2)  ·  Amiodarone (1)  ·  Aspirin (1)

Sponsors

M.D. Anderson Cancer Center (11)  ·  National Taiwan University Hospital (4)  ·  Shanghai Jiao Tong University School of Medicine (4)  ·  Beijing Tiantan Hospital (3)  ·  National Eye Institute (NEI) (3)  ·  Sun Yat-sen University (3)  ·  Vyne Therapeutics Inc. (3)  ·  Xijing Hospital (3)  ·  GlaxoSmithKline (2)  ·  Hovione Scientia Limited (2)  ·  Mahidol University (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  State University of New York - Downstate Medical Center (2)  ·  University of Calgary (2)  ·  University of California, Los Angeles (2)

Countries

United States (53)  ·  China (20)  ·  Israel (6)  ·  Canada (5)  ·  Taiwan (4)  ·  Pakistan (3)  ·  Australia (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Spain (2)  ·  Thailand (2)  ·  Austria (1)  ·  Bulgaria (1)

Top investigators

Yung-Chie Lee, MD, PhD (4)  ·  Zhongxing Liao, MD (3)  ·  Adhiratha Boonyasiri, MD (2)  ·  Catherine A Cukras, M.D. (2)  ·  Jin-Shing Chen, MD, PhD (2)  ·  Rauno Joks, MD (2)  ·  Xiang Luo (2)  ·  Adnan H Siddiqui, MD PhD (1)  ·  Ajay Niranjan, MD, MBA (1)  ·  Allen Lamb, DO (1)  ·  Anxin Wang, PhD (1)  ·  Avner Shemer, Prof. (1)

Results publications

PMID 28887388, PMID 34487721, PMID 10557349, PMID 11306611, PMID 11880505, PMID 15536785, PMID 15760647, PMID 16033424, PMID 17909152, PMID 17980667, PMID 18071725, PMID 18212521, PMID 19628804, PMID 19895780, PMID 20705929, PMID 21169826, PMID 21450915, PMID 21450917, PMID 21450918, PMID 21737808, PMID 21909339, PMID 22057194, PMID 22323011, PMID 2234831, PMID 22357572, PMID 22589436, PMID 22632907, PMID 22943144, PMID 22967863, PMID 23085382, PMID 23489754, PMID 23566357, PMID 23970502, PMID 24711047, PMID 25003359, PMID 25348221, PMID 25491305, PMID 25888869, PMID 26231264, PMID 26396030, PMID 26510778, PMID 27019421, PMID 27673305, PMID 27718519, PMID 27861741, PMID 28275199, PMID 28564557, PMID 28929560, PMID 29232823, PMID 29444972

NIH funding

R01CA026582 (3), K01AA026005 (2), P01CA124787 (2), 2005 (1), 2023 (1), 2UM1AI104681-08 (1), R01HL132448 (1), R01NS095937 (1), R21AA023150 (1), R21CA158902 (1)